BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17667919)

  • 1. Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation.
    Minas V; Rolaki A; Kalantaridou SN; Sidiropoulos J; Mitrou S; Petsas G; Jeschke U; Paraskevaidis EA; Fountzilas G; Chrousos GP; Pavlidis N; Makrigiannakis A
    Br J Cancer; 2007 Sep; 97(5):637-45. PubMed ID: 17667919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone (CRH) is expressed in the human cervical carcinoma cells (HeLa) and upregulates the expression of Fas ligand.
    Taliouri E; Vrekoussis T; Vergetaki A; Agorastos T; Makrigiannakis A
    Tumour Biol; 2013 Feb; 34(1):125-30. PubMed ID: 23076876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abortion is associated with increased expression of FasL in decidual leukocytes and apoptosis of extravillous trophoblasts: a role for CRH and urocortin.
    Minas V; Jeschke U; Kalantaridou SN; Richter DU; Reimer T; Mylonas I; Friese K; Makrigiannakis A
    Mol Hum Reprod; 2007 Sep; 13(9):663-73. PubMed ID: 17704118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of corticotropin-releasing hormone in pre-eclampsia induces expression of FasL in maternal macrophages and extravillous trophoblast apoptosis.
    Petsas G; Jeschke U; Richter DU; Minas V; Hammer A; Kalantaridou S; Toth B; Tsatsanis C; Friese K; Makrigiannakis A
    Mol Hum Reprod; 2012 Nov; 18(11):535-45. PubMed ID: 22763913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WAP four-disulfide core domain protein 2 mediates the proliferation of human ovarian cancer cells through the regulation of growth- and apoptosis-associated genes.
    Chen Y; Mu X; Wang S; Zhao L; Wu Y; Li J; Li M
    Oncol Rep; 2013 Jan; 29(1):288-96. PubMed ID: 23129262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing hormone receptors mediate apoptosis via cytosolic calcium-dependent phospholipase A₂ and migration in prostate cancer cell RM-1.
    Jin L; Li C; Li R; Sun Z; Fang X; Li S
    J Mol Endocrinol; 2014 Jun; 52(3):255-67. PubMed ID: 24776847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restraint-induced corticotrophin-releasing hormone elevation triggers apoptosis of ovarian cells and impairs oocyte competence via activation of the Fas/FasL system.
    Li CY; Li ZB; Kong QQ; Han X; Xiao B; Li X; Chang ZL; Tan JH
    Biol Reprod; 2018 Oct; 99(4):828-837. PubMed ID: 29668880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of urocortin and corticotropin-releasing hormone receptors in the horse thyroid gland.
    Squillacioti C; De Luca A; Alì S; Paino S; Liguori G; Mirabella N
    Cell Tissue Res; 2012 Oct; 350(1):45-53. PubMed ID: 22684850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of corticotropin-releasing hormone family peptides in androgen receptor and vitamin D receptor expression and translocation in human breast cancer MCF-7 cells.
    Jin L; Chen C; Guo R; Wan R; Li S
    Eur J Pharmacol; 2012 Jun; 684(1-3):27-35. PubMed ID: 22494987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
    O'Connell J; Bennett MW; O'Sullivan GC; Roche D; Kelly J; Collins JK; Shanahan F
    J Pathol; 1998 Nov; 186(3):240-6. PubMed ID: 10211111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1 alpha corticotropin-releasing hormone receptor.
    McEvoy AN; Bresnihan B; FitzGerald O; Murphy EP
    Arthritis Rheum; 2001 Aug; 44(8):1761-7. PubMed ID: 11508426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of the integrin-linked kinase gene induces the apoptosis in ovarian carcinoma.
    Liu Q; Xiao L; Yuan D; Shi X; Li P
    J Recept Signal Transduct Res; 2012 Apr; 32(2):120-7. PubMed ID: 22384810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of prenatal stress on the expression of corticotrophin-releasing hormone and its receptors in the hypothalamus and amygdala in male and female rats.
    Zohar I; Weinstock M
    J Neuroendocrinol; 2011 Apr; 23(4):320-8. PubMed ID: 21306450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells.
    Zhu Q; Liu JY; Yang CM; Xu HW; Zhang AZ; Cui Y; Wang HB; Qin CY; Li YQ
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1071-7. PubMed ID: 16957513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of urocortin and corticotropin-releasing hormone receptors in the bovine adrenal gland.
    Squillacioti C; De Luca A; Liguori G; Paino S; Mirabella N
    Gen Comp Endocrinol; 2011 Jul; 172(3):416-22. PubMed ID: 21504748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunolocalization of corticotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial carcinoma: CRHR1 as a potent prognostic factor.
    Sato N; Takagi K; Suzuki T; Miki Y; Tanaka S; Nagase S; Warita H; Fukudo S; Sato F; Sasano H; Ito K
    Int J Gynecol Cancer; 2014 Nov; 24(9):1549-57. PubMed ID: 25254562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
    Elnemr A; Ohta T; Yachie A; Kayahara M; Kitagawa H; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
    Int J Oncol; 2001 Jan; 18(1):33-9. PubMed ID: 11115536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single episode of restraint stress regulates central corticotrophin- releasing hormone receptor expression and binding in specific areas of the mouse brain.
    Greetfeld M; Schmidt MV; Ganea K; Sterlemann V; Liebl C; Müller MB
    J Neuroendocrinol; 2009 May; 21(5):473-80. PubMed ID: 19302188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.